Raymond James Financial Services Advisors, Inc. - TAKEDA PHARMACEUTICAL CO LTD ownership

TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 278 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q2 2022. The put-call ratio across all filers is 0.15 and the average weighting 0.1%.

Quarter-by-quarter ownership
Raymond James Financial Services Advisors, Inc. ownership history of TAKEDA PHARMACEUTICAL CO LTD
ValueSharesWeighting
Q3 2023$705,873
-34.2%
45,628
-33.2%
0.00%
-50.0%
Q2 2023$1,073,240
-6.4%
68,316
-1.8%
0.00%0.0%
Q1 2023$1,146,954
+4.4%
69,597
-1.2%
0.00%0.0%
Q4 2022$1,098,563
-46.3%
70,421
-55.4%
0.00%
-60.0%
Q3 2022$2,046,000
-10.7%
157,746
-3.3%
0.01%0.0%
Q2 2022$2,291,000
+2.9%
163,174
+5.0%
0.01%
+25.0%
Q1 2022$2,226,000
+11.2%
155,462
+5.9%
0.00%0.0%
Q4 2021$2,001,000
-32.1%
146,838
-18.4%
0.00%
-33.3%
Q3 2021$2,949,000
+1.8%
180,041
+4.6%
0.01%0.0%
Q2 2021$2,897,000
+7.9%
172,128
+17.1%
0.01%0.0%
Q1 2021$2,685,000
+104.3%
147,054
+103.7%
0.01%
+100.0%
Q4 2020$1,314,000
+39.3%
72,198
+36.5%
0.00%0.0%
Q3 2020$943,000
+4.8%
52,883
+5.4%
0.00%0.0%
Q2 2020$900,000
+119.0%
50,176
+85.3%
0.00%
+50.0%
Q1 2020$411,000
+26.1%
27,083
+64.0%
0.00%
+100.0%
Q4 2019$326,000
+4.2%
16,510
-9.4%
0.00%0.0%
Q3 2019$313,000
-26.9%
18,226
-24.6%
0.00%
-50.0%
Q2 2019$428,000
-18.9%
24,186
-6.6%
0.00%0.0%
Q1 2019$528,00025,9040.00%
Other shareholders
TAKEDA PHARMACEUTICAL CO LTD shareholders Q2 2022
NameSharesValueWeighting ↓
TFG Asset Management GP Ltd 1,903,662$29,449,6525.37%
MANAGED ASSET PORTFOLIOS, LLC 1,736,416$26,862,3564.12%
Y.D. More Investments Ltd 1,381,550$21,372,5794.11%
Clean Yield Group 533,157$8,167,9653.62%
XY Capital Ltd 143,697$2,222,9931.28%
Mondrian Investment Partners LTD 4,081,715$61,225,7251.26%
Capricorn Fund Managers Ltd 204,892$3,169,6791.10%
Legacy Wealth Asset Management, LLC 124,967$1,933,2390.71%
HAP Trading, LLC 263,679$4,079,1140.65%
BRANDES INVESTMENT PARTNERS, LP 1,802,036$27,877,4930.54%
View complete list of TAKEDA PHARMACEUTICAL CO LTD shareholders